drugset / Trial / NCT06228079
Adjuvant vs Surgery Only in Early-stage Recurrent NPC
Phase 3
Recruiting
176 enrolled
Eye & ENT Hospital of Fudan University
Changhai Hospital · collabFujian Medical University Union Hospital · collabPeople's Hospital of Guangxi Zhuang Autonomous Region · collabShanghai 6th People's Hospital · collabShanghai Zhongshan Hospital · collabShenzhen Second People's Hospital · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
Adjuvant Therapy Versus Endoscopic Surgery Alone in Early-stage Recurrent Nasopharyngeal Carcinoma: A Multicenter Randomized Controlled Trial
Timeline
- Start
- 2024-06-25
- Primary completion
- 2028-06-30
- Completion
- 2028-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | — | — |
| Subject | Toripalimab | Monoclonal antibody | — | — |